LFG
XERS icon

Larson Financial Group’s Xeris Biopharma Holdings XERS Stock Holding History

Larson Financial Group’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.56K Buy
955
+851
+818% +$5.43K ﹤0.01% 2564
2026
Q1 		$603 Buy
+104
New +$690 ﹤0.01% 3280
2025
Q4 		– Sell
-400
Closed -$3.26K – 3689
2025
Q3 		$3.26K Buy
+400
New +$2.66K ﹤0.01% 2515

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Larson Financial Group's XERS Position: Q2 2026 in Review

Larson Financial Group increased its Xeris Biopharma Holdings (XERS) stake by 818% in Q2 2026, buying an estimated $5.43K and bringing the position to 955 shares worth $7.56K. The position accounts for ﹤0.01% of the portfolio, ranked #2564.

Larson Financial Group first reported a position in XERS in Q3 2025 and has held it in 3 quarters since. 240 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • Larson Financial Group held 955 shares of Xeris Biopharma Holdings worth $7.56K as of Q2 2026.
  • Larson Financial Group bought 851 Xeris Biopharma Holdings shares in Q2 2026, an estimated $5.43K.
  • Xeris Biopharma Holdings made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #2564 holding.
  • Larson Financial Group first reported a position in Xeris Biopharma Holdings in Q3 2025 and has held it in 3 quarters since.
  • 240 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.